Acute liver failure

Annals of Saudi Medicine

Volumn 18, Issue 4, 1998, Pages 318-326

  Khuroo, Mohammad Sultan ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; COTRIMOXAZOLE; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TUBERCULOSTATIC AGENT;

BLOOD CLOTTING DISORDER; BRAIN EDEMA; DRUG OVERDOSE; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS B; HEPATITIS E; HEPATITIS NON A NON B; HUMAN; INFECTION; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUICIDE ATTEMPT;

EID: 0032462006     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1998.318     Document Type: Review

References (78)

1. Hoofnagle JH, Carilhers RL Jr., Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995;21:240-52.
2. Lee WM. Acute liver failure. Am J Med 1994;96(Suppl A):3-9.
3. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: clinical presentation and use of prognostic index. Gut 1986;27:1377-81.
4. Walia BN, Singh S, Marwaha RK, Bhusnurmath SR, Dilawari JB. Fulminant hepatic failure and acute intravascular haemolysis as presenting manifestations of Wilson's disease in young children. J Gastroenterol and Hepatol 1992;7:370-3.
5. Maggiore G, Porta G, Bernard O, Hadchouel M, Alvarez F, Homberg J-C, et al. Autoimmune hepatitis with initial presentation as acute liver failure in young children. J Pediatr 1990;116:280-2.
6. Flowers MA, Heathcote J, Wanless IR, Morris S, Reynold WJ, Cameron J, et al. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy. Ann Intern Med 1990;112:381-2.
7. Saracco G, Macagno S, Rosina F. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiological and clinical survey. Ann Intern Med 1988;108:380-3.
8. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, editors. Progress in liver failure. New York: Grune and Stratton, 1970:292-8.
9. Gimson AES, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology 1986;6:288-94.
10. Khuroo MS, Dar MY. Subacute hepatic failure: experience at Institute of Medical Sciences, Srinagar. Ind J Gastroenterol 1993;12(Suppl):7-10.
11. Tandon BN. Subacute hepatic failure: definition, nomenclature and criteria for diagnosis. Ind J Gastroenterol 1993;12(suppl):5-6.
12. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;352:273-5.
13. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definition and causes. Semin Liver Dis 1986;6:97-106.
14. Sherlock S, Dooley J. Diseases of the liver and biliary system. 9th edition. Oxford: Blackwell Scientific Publications, 1993.
15. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Eng J Med 1997;337:473-8.
16. Khuroo MS, Khuroo N. Hepatitis E: global epidemiology with special reference to impact of the disease in India and the South East of Asia. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral hepatitis and liver disease. Turin: Edizioni Minerva Medica, 1997:601-8.
17. O'Grady JG, Portmann B, Williams R. Fulminant hepatic failure. In: Schiff L, Schiff ER, editors. Diseases of the liver. Philadelphia: Lippincott Company 1993:1077-90.
18. Mahler H, Pasi A, Kramer JM, Schulte P, Scoging AE, Bar W, Krahenbuhl S. Fulminant liver failure in association with the emetic of Bacillus cereus. N Eng J Med 1997;336:1142-8.
19. Bray GP. Liver failure induced by paracetamol. Brit Med J 1993;306:157-8.
20. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995;346:547-52.
21. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995;22:588-97.
22. Schiødt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337:1112-7.
23. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981;70:252-5.
24. Nanda SK, Yalchinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol 1994;42:133-7.
25. Acharya SK, Dasarathy S, Kumer TL, Sushma S, Prasanna KSU, Tandon A, et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996; 23:1448-55.
26. Khuroo MS. Acute liver failure in India. Hepatology 1997;26:244-6.
27. Farci P, Alter H, Shimoda A, Govindarajan S, Cheung L, Melpolder JC, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med 1997;335:631-4.
28. Lian TJ, Jeffers L, Reddy RK, Silva MO, Cheinguer H, Findor A, et al. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 1993;104:556-62.
29. Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentric study. J Gastroenterol Hepatol 1991;6:159-64.
30. Wright TL. Etiology of fulminant hepatic failure: is another virus involved? Gastroenterology 1993;104:640-53.
31. Fagan EA. Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology 1994;19:1307-2.
32. Khuroo MS. Discovery of hepatitis G virus. Ann Saudi Med 1997;17:209-16.
33. Heringlake S, Osterkemp S, Trautwein C, Tillmann HL, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996;348:1626-9.
34. Ede RJ, Williams R. Hepatic encephalopathy and cerebral edema. Semin Liver Dis 1986;6:107-18.
35. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;34:157-8.
36. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996;16:403-12
37. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, et al. Prospective study of bacterial infection in acute liver failure: an analysis of 50 patients. Hepatology 1990;11:49-53.
38. Chu CM, Chiu KW, Liaw YF. The prevalence and prognostic significance of spontaneous bacterial peritonitis in severe acute hepatitis with ascites. Hepatology 1992;15:799-803.
39. Rolando N, Philipott-Howard J, Williams R. Bacterial and fungal infections in acute liver failure. Semin Liver Dis 1996;16:389-400.
40. Ellis A, Wendon J. Circulatory, respiratory, cerebral and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 1996;16:379-88.
41. Losser MR, Payen D. Mechanisms of liver damage. Semin Liver Dis 1996;16:357-67.
42. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Robers EA, Philips MJ, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. J Clin Invest 1989;84:1063-9.
43. 2 in treatment of fulminant hepatic failure (abstract). Hepatology 1992;16:88A.
44. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Eng J Med 1991;324:1852-7.
45. Kaplan MM. Current concepts. Acute fatty liver of pregnancy. N Engl J Med 1985;313:367-70.
46. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia -eclampsia. Am J Obstet Gynecol 1986;155:501-9.
47. Knox TA, Olans LB. Liver disease in pregnacy. N Engl J Med 1996;335:569-76.
48. Bhaduri B, Mieli-Vergani G. Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 1996;16:345-55.
49. Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases with roentgenologic hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980;68:113-21.
50. Vons C, Bourstyn E, Bonnet P, Smadja C, Szekely AM, Franco D. Results of portal systemic shunts in Budd-Chiari syndrome. Ann Surg 1986;203:366-70.
51. Ringe B, Lang H, Oldhafer K-J, Gebel M, Flemming P, Georgii A, et al. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single center experience with 50 patients. Hepatology 1995;21:1337-44.
52. Oches A, Sellinger M, Haag K, Nöldge G, Herbst EW, Walter E, Gerok W, et al. Transjugular intrahepatic portosytemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993;18:217-25.
53. Cashland TM, Shaw BW Jr., Tape E. The American experience with transplantation for acute liver failure. Semin Liver Dis 1996;16:427-32.
54. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996; 16:415-25.
55. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis: the Paul Brousse experience. Ann Surg 1995;222:109-19.
56. Moritz MJ, Jarrell BE, Munoz SJ, Maddrey WC. Regeneration of the native liver after heterotopic liver transplantation for fulminant hepatic failure. Transplantation 1993;55:952-4.
57. Mortiz MJ, Jarrell BE, Armenti V, Radomski J, Carabasi RA, Zeitouni G, et al. Heterotopic liver transplantation for fulminant hepatic failure: a bridge to recovery. Transplantation 1990;50:524-6.
58. Gubenatis G, Pichlmayr R, Kemnitz J, Gratz K. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg 1991;15:660-5.
59. Shaw BH Jr, Cattral M, Langas AN, Heffron TG, Fox IJ. Orthotopic auxiliary liver transplantation: the treatment of choice for acute liver failure? [abstract]. Hepatology 1993;18:66A.
60. O'Grady LG, Alexander GJM, Hayllar K, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
61. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986;6:648-51.
62. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis 1986; 6:129-37.
63. Lee WM, Sorrell MF. Developing a world view toward acute liver failure. Hepatology 1996;24:270-1.
64. Gerlach J. Hybrid Liver support. Int J Artif Organs 1996;19:1-2.
65. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-92.
66. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis 1996;165:435-44.
67. Sussman NL, Chong MG, Koussayer T, He D-E, Shang TA, Whisennand HH, et al. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992;16:60-5.
68. Sussman NL, Finegold MJ, Kelly JH. Recovery from syncytial giant-cell hepatitis (SGCH) following treatment with an extracorporeal liver assist device (ELAD) (abstract). Hepatology 1992;16:51A.
69. Moscioni AD, Roy-Chowdhury J, Barbour R, Bown LL, Roy-Chowdhury N, Competiello LS, et al. Human liver cell transplantation: prolonged function in athyraic rats. Gastroenterology 1989;96:1546-51.
70. Moscioni AD, Nanney L, Brown L, Barbour R, Demetriou AA. Transplantation of microcarrier-attached human hepatocytes into Gunn rats. Surg Forum 1987;38:385-7.
71. Demetriou AA, Whiting JF, Feldman D, Levenson SM, Roy-Chowdhury N, Mosconi AP, et al. Replacement of liver function in rat by transplantation of microcarrier-attache hepatocytes. Science 1986;233:1190-2.
72. Rozga J, Bellew T, Moscioni AD, Demetriou AA. Transplantation of microencapsulated hepatocytes into analbuminemic rats. Surg Forum 1991;42:419-21.
73. Roy-Chowdhury J, Grossman M, Gupta S, Roy-Chowdhury N, Baker JR, Wilson JM. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR deficient rabbits. Science 1991;254:1802-5.
74. Grossman M, Wilson JM. Frontiers in gene therapy: LDL receptor replacement for hypercholesterolemia. J Lab Clin Med 1992;119:457-60.
75. Demetriou AA, Reisner A, Sanchez J, Levenson SM, Moscioni AD, Roy-Chowdhury J. Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats. Hepatology 1988;8:1006-9.
76. Fair J, Maley W, Stephenson G, Kittur D, Klein C. Extracorporeal porcine liver perfusion as a successful bridge to orthotopic liver transplantation (OLT) (abstract). Gastroenterology 1993;104:899A.
77. Chari RS, Collings BH, Magee JC, DiMaio JM, Kirk AD, Harland RC, et al. Brief report: treatment of hepatic failure with ex vivo pig liver perfusion followed by liver transplantation. N Engl J Med 1994;331:234-7.
78. Cramer DV. The use of xenografts for acute hepatic failure. Transplant Proc 1995;27:80-2.